RECENT NEWS

Twenty-seven species of bacteria and fungi among the hundreds that live in people’s mouths have been collectively tied to a 3.5 times greater risk of developing pancreatic cancer, a study led by NYU Langone Health and its Perlmutter Cancer Center shows.

A single joint executive team is to be established at the Department of Health and Social Care (DHSC) and NHS England as part of the transition to one organisation.

The Institute of Biomedical Science (IBMS) has announced that it has commissioned Lord Patrick Carter to lead an independent UK-wide review of pathology services to benchmark today’s services and workforce to guide tomorrow’s decisions.

The Centre for Process Innovation (CPI) has published three interconnected reports offering the most comprehensive analysis to date of the challenges facing UK MedTech innovators.

Diagnostics firm BHR Biosynex has announced two exclusive distribution deals for new analyser platforms in the UK.

A new partnership between OGT, a global leader in genomic research and diagnostic solutions, and QIAGEN Digital Insights (QDI), a leading provider of genomic interpretation and analysis tools, expands OGT’s bioinformatics capabilities by integrating QIAGEN’s advanced tertiary analysis solution, QCI Interpret, with its SureSeq NGS panels.

Proscia, a pathology AI company, has announced the next step in its collaboration with Amazon Web Services (AWS) to address two of digital pathology’s most pressing challenges: managing surging data volumes and standardising siloed data.

The September issue of PIP has now been published and is available to read online.

A new serology test for Lyme disease shows promise to streamline the testing protocol and to enable the diagnosis of patients in very early stages of the disease.

A team of immunologists at the University of Massachusetts Amherst has discovered a pre-wired ability in ‘resting’ T cells to remember past viral foes, a promising breakthrough for targeted cancer therapies.

Genomics England has announced the appointment of Dr Natalie Banner as its Chief Ethics and Engagement Officer.

Scientists have developed a new test that can decode when a cancer tumour first started growing and how fast it is growing, potentially allowing doctors to accurately predict when a patient will need treatment.

Beckman Coulter Diagnostics has launched the industry's first fully automated Brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test.

A new report from The Royal College of Pathologists (RCPath) reveals that three-quarters of immunology services in the UK do not currently have enough staff to meet clinical demand.

A major trial supported by the University College London Hospitals Biomedical Research Centre aims to transform the diagnosis of Alzheimer’s disease through a simple blood test.

AI-powered digital pathology firm PathAI has announced new partnerships with AI pathology innovators Mindpeak, Stratipath, and Primaa. Artificial intelligence products from the three firms will soon be available via PathAI's AISight Dx image management system.

Sterilab Services, a leading supplier of diagnostic consumables in the UK, has been appointed as an authorised distributor for Copan, the globally recognised brand in microbiological specimen collection and transport.

A ground-breaking UK-wide scientific study will help improve the lives of future generations by studying 30,000 children born in 2026.

The Government has announced it is to roll out a new system of league tables for England’s NHS Trusts, as it aims to deliver better patient care following what it says is record investment.

A new report has shown that the UK can build a more preventive, efficient, and resilient healthcare system fit for the future by prioritising investment in in vitro diagnostics (IVDs) across the NHS.